Author

I. G. Cannell

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. Nicholls· 1 shared CRUK IMAXT Grand Challenge Team· 1 shared D. Bressan· 1 shared G. J. Hannon· 1 shared K. Kania· 1 shared K. Sawicka· 1 shared S. A. Wild· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Nicholls

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivDec 9, 2021

Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies.

S. A. Wild, I. G. Cannell, K. Kania…·K. Sawicka

The paper uses clonal transcriptomics to identify mechanisms of chemoresistance in TNBC and suggests asparagine deprivation as a potential combination therapy.

DOI 10.7554/elife.80981

mousescRNA-seq

𝕏 PostBluesky